These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12782969)

  • 21. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.
    Llerena A; Dorado P; Peñas-Lledó EM; Cáceres MC; De la Rubia A
    Pharmacogenomics J; 2007 Dec; 7(6):408-10. PubMed ID: 17325735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytochrome P450*2D6 gene polymorphism in Chinese population].
    Tao E; Liu Z; Chen B; Pan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):34-7. PubMed ID: 9456373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CYP2D6 genotypes and personality traits in healthy individuals.
    Kirchheiner J; Lang U; Stamm T; Sander T; Gallinat J
    J Clin Psychopharmacol; 2006 Aug; 26(4):440-2. PubMed ID: 16855473
    [No Abstract]   [Full Text] [Related]  

  • 25. CYP2D6 polymorphism and the presence of anti-LKM-1 in patients with chronic hepatitis C.
    Hijikata M; Miyakawa H; Matsushita M; Kako M; Ohta Y; Mishiro S
    Biochem Biophys Res Commun; 2000 Apr; 270(3):922-6. PubMed ID: 10772926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study.
    Rau T; Wohlleben G; Wuttke H; Thuerauf N; Lunkenheimer J; Lanczik M; Eschenhagen T
    Clin Pharmacol Ther; 2004 May; 75(5):386-93. PubMed ID: 15116051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and novelty seeking personality in healthy females.
    Shimizu E; Hashimoto K; Ohgake S; Koizumi H; Okamura N; Koike K; Fujisaki M; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):99-103. PubMed ID: 16236416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects.
    Shibuya N; Suzuki A; Sadahiro R; Kamata M; Matsumoto Y; Goto K; Hozumi Y; Otani K
    Neurosci Lett; 2010 Nov; 485(3):194-7. PubMed ID: 20849924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study.
    Teh LK; Zilfalil BA; Marina I; Rosemi BS; Ismail R
    J Clin Pharm Ther; 2004 Dec; 29(6):559-64. PubMed ID: 15584944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.
    van der Padt A; van Schaik RH; Sonneveld P
    Neth J Med; 2006 May; 64(5):160-2. PubMed ID: 16702617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics and personality traits in patients with social anxiety disorder: a case-control study in South Africa.
    Lochner C; Hemmings S; Seedat S; Kinnear C; Schoeman R; Annerbrink K; Olsson M; Eriksson E; Moolman-Smook J; Allgulander C; Stein DJ
    Eur Neuropsychopharmacol; 2007 Apr; 17(5):321-7. PubMed ID: 16899354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP2D6 and CYP1A1 mutations in the Turkish population.
    Aydin M; Hatirnaz O; Erensoy N; Ozbek U
    Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice.
    Mulder H; Herder A; Wilmink FW; Tamminga WJ; Belitser SV; Egberts AC
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):107-14. PubMed ID: 16294366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
    Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2D6 in the brain: genotype effects on resting brain perfusion.
    Kirchheiner J; Seeringer A; Godoy AL; Ohmle B; Maier C; Beschoner P; Sim EJ; Viviani R
    Mol Psychiatry; 2011 Mar; 16(3):237, 333-41. PubMed ID: 20368706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6.
    Niwa T; Hiroi T; Tsuzuki D; Yamamoto S; Narimatsu S; Fukuda T; Azuma J; Funae Y
    Brain Res Mol Brain Res; 2004 Oct; 129(1-2):117-23. PubMed ID: 15469888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of phenylalanine 483 in cytochrome P450 2D6 is strongly substrate dependent.
    Lussenburg BM; Keizers PH; de Graaf C; Hidestrand M; Ingelman-Sundberg M; Vermeulen NP; Commandeur JN
    Biochem Pharmacol; 2005 Oct; 70(8):1253-61. PubMed ID: 16135359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs.
    Savino M; Seripa D; Gallo AP; Garrubba M; D'Onofrio G; Bizzarro A; Paroni G; Paris F; Mecocci P; Masullo C; Pilotto A; Santini SA
    Clin Lab; 2011; 57(11-12):887-93. PubMed ID: 22239018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
    Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
    Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.